Because both are BPC-based supplements, its best to avoid stacking similar products unnecessarily and to follow each products label directions
an early phase 1b study reported that co-administration was feasible and that each components pharmacokinetics were not meaningfully altered by the other, which motivated the phase 3 program [3]
How It Works Tesamorelin is an FDA-approved GHRH analog that has been demonstrated in randomized controlled trials to significantly reduce visceral adipose tissue (the metabolically dangerous fat that accumulates around your organs)
A Phase 2 trial for HIV-associated lipodystrophy was discontinued in 2006-2007 after a participant death, and development was never resumed
Still, many in the performance and injury rehab communities use BPC-157 off-label for: Chronic tendinopathies Joint degeneration Gut permeability Accelerated post-surgery rehab "Despite limited clinical trials, the number of consistent anecdotal reports and supporting animal research is what drives interest in BPC-157," notes Irrgang and colleagues, Orthopaedic Journal of Sports Medicine